2023
DOI: 10.1016/bs.acc.2023.08.004
|View full text |Cite
|
Sign up to set email alerts
|

Advances in preeclampsia testing

Jessica J. Miller,
Victoria Higgins,
Annie Ren
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 128 publications
0
1
0
Order By: Relevance
“…Substantial research has been undertaken to identify females at high risk for preeclampsia, preferably with low-cost tools that can be used widely. Groups that have evaluated the utility of clinical and laboratory biomarkers to assess risk of preeclampsia (21)(22)(23)(24) have reported moderate-high results (AUC between 0.80 and 0.90) when using such data within machine learning or neural network algorithms as shown by Jhee et al, Marić et al,Neocleous et al and Li et al (8,9,20,25) At the same time, there has been considerable interest and research into the role of PlGF and sFlt-1 in preeclampsia testing (26). Approaches based on models using PlGF alone or the ratio of sFlt-1/PlGF have shown good performance and have been implemented for short term preeclampsia risk prediction and for assisting preeclampsia diagnosis in the second and third trimesters.…”
Section: Discussionmentioning
confidence: 99%
“…Substantial research has been undertaken to identify females at high risk for preeclampsia, preferably with low-cost tools that can be used widely. Groups that have evaluated the utility of clinical and laboratory biomarkers to assess risk of preeclampsia (21)(22)(23)(24) have reported moderate-high results (AUC between 0.80 and 0.90) when using such data within machine learning or neural network algorithms as shown by Jhee et al, Marić et al,Neocleous et al and Li et al (8,9,20,25) At the same time, there has been considerable interest and research into the role of PlGF and sFlt-1 in preeclampsia testing (26). Approaches based on models using PlGF alone or the ratio of sFlt-1/PlGF have shown good performance and have been implemented for short term preeclampsia risk prediction and for assisting preeclampsia diagnosis in the second and third trimesters.…”
Section: Discussionmentioning
confidence: 99%
“…Preeclampsia, a significant hypertensive disorder occurring during pregnancy, poses considerable risks to both maternal and fetal health globally [ 1 ]. Perinatal mortality constitutes about 15%, which includes the intra-uterine demise of the fetus (8.6%), stillbirths (2.15%), and neonatal deaths (4.3%) [ 1 ].…”
Section: Introductionmentioning
confidence: 99%
“…Preeclampsia, a significant hypertensive disorder occurring during pregnancy, poses considerable risks to both maternal and fetal health globally [ 1 ]. Perinatal mortality constitutes about 15%, which includes the intra-uterine demise of the fetus (8.6%), stillbirths (2.15%), and neonatal deaths (4.3%) [ 1 ]. It is characterized by the onset of hypertension (systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg) and proteinuria (≥ 300 mg/24 hours) after the 20 th week of gestation in previously normotensive women.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation